548 556
549 557
550 558
551 559
552 561
553 562
554 563
555 564
556 565
557 566
558 567
559 568
560 569
561 570
562 571
563 572
564 573
565 574
566 575
567 576
568 577
569 579
570 580
571 581
572 582
573 583
574 584
575 585
576 586
577 587
578 588
579 589
580 590
581 591
582 592
PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING AND SIMULATIONS
Principles, Methods, and Applications in the Pharmaceutical Industry
Second Edition
Sheila Annie Peters
Merck Healthcare
Translational Quantitative Pharmacology
Darmstadt
Germany
This edition first published 2022
© 2022 by John Wiley & Sons, Inc.
Edition History Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations: Principles, Methods, and Applications in the Pharmaceutical Industry, 1st Edition, © 2012 by John Wiley & Sons, Inc.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.
The right of Sheila Annie Peters to be identified as the author of this work has been asserted in accordance with law.
Registered Office John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USA
Editorial Office 111 River Street, Hoboken, NJ 07030, USA
For details of our global editorial offices, customer services, and more information about Wiley products visit us at www.wiley.com.
Wiley also publishes its books in a variety of electronic formats and by print‐on‐demand. Some content that appears in standard print versions of this book may not be available in other formats.
Limit of Liability/Disclaimer of Warranty In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of experimental reagents, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each chemical, piece of equipment, reagent, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. While the publisher and authors have used their best efforts in preparing this work, they make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives, written sales materials, or promotional statements for this work. The fact that an organization, website, or product is referred to in this work as a citation and/or potential source of further information does not mean that the publisher and authors endorse the information or services the organization, website, or product may provide or recommendations it may make. This work is sold with the understanding that the publisher is not engaged in rendering professional services. The advice and strategies contained herein may not be suitable for your situation. You should consult with a specialist where appropriate. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was written and when it is read. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.
Library of Congress Cataloging‐in‐Publication Data Names: Peters, Sheila Annie, author. Title: Physiologically based pharmacokinetic (PBPK) modeling and simulations : principles, methods, and applications in the pharmaceutical industry / Sheila Annie Peters. Description: Second edition. | Hoboken, NJ : Wiley, 2021. | Includes bibliographical references and index. Identifiers: LCCN 2021038143 (print) | LCCN 2021038144 (ebook) | ISBN 9781119497684 (hardback) | ISBN 9781119497769 (adobe pdf) | ISBN 9781119497790 (epub) Subjects: MESH: Pharmacokinetics | Drug Design | Models, Biological Classification: LCC RM301.5 (print) | LCC RM301.5 (ebook) | NLM QV 38 | DDC 615.7–dc23 LC record available at https://lccn.loc.gov/2021038143 LC ebook record available at https://lccn.loc.gov/2021038144
Cover Design: Wiley
Cover Image: Courtesy of Sheila Annie Peters
To my readers whose tremendous support for the first edition inspired me to give my best to this edition.
PREFACE TO THE SECOND EDITION
I am excited to bring out this much improved second edition, encouraged by the success of the first edition of “Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations: Principles, Methods, and Applications in the Pharmaceutical Industry”. The applications of PBPK modeling and simulations have exponentially grown since the publication of the first edition of the book in 2012. Since that time, a surge in PBPK regulatory submissions has prompted the regulatory agencies to release guidelines for the reporting of PBPK modeling results that accompany submissions.
The adverse impact of the COVID‐19 pandemic on global economies is still being evaluated. Pharma companies have had their fair share of losses too. Clinical studies for various indications have been affected by stretched healthcare infrastructure,